Search Results
Klein, R., Peto, T., Bird, A. és mtsai: The epidemiology of age-related macular degeneration. Am. J. Ophthalmol., 2004, 137 , 486–495. Bird A. The epidemiology of age-related
Zarbin, M. A.: Current concepts in the pathogenesis of age-related macular degeneration. Arch. Ophthalmol., 2004, 122 , 598–614. Zarbin M. A
Zarbin, M. A.: Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol., 2004, 122 , 598–614. Zarbin M. A
Jager, R. D., Mieler, W. F., Miller, J. W.: Age-related macular degeneration. N. Engl. J. Med., 2008, 358 , 2606–2617. Miller J. W
Introduction Age-related macular degeneration (AMD) is a progressive disease that may be associated with blurred or no vision in the center of the visual field [ 1 ]. Macular degeneration causes the macula to lose its natural
. Augenheilkd., 2004, 221 (12), 1062. Machalińska, A., Safranow, K., Dziedziejko, V., et al.: Different populations of circulating endothelial cells in patients with age-related macular degeneration: a novel insight into
Seddom, J. M., Rifai, N.: Association with C-reactive protein and age-related macular degeneration. JAMA, 2004, 281 , 704–710. Rifai N. Association with C-reactive protein and
macular degeneration is associated with increased vascular endothelial goss factor, hemorrheology and endothelial dysfunction. Ophthalmology, 2001, 108 , 705–710. Hope-Ross M. Age-related
: a new concept in ophthalmology Arch. Ophthalmol. 39 123 – 132 . [5]. G. Y. H. Lip A. Blann M. Hope-Ross 2001 Age-related macular degeneration is associated with increased vascular endothelial goss factor, hemorrheology and
–179. 2 Machalińska, A., Kawa, M. P., Marlicz, W. S., et al.: Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible
